Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR PreveCeutical Medical Inc (18H.BE) Follow Add holdings 0.0170 0.0000 (0.00%) At close: April 23 at 7:31:03 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 18H.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 18H.BE View More All News Press Releases SEC Filings PreveCeutical Announces Up-Sized Non-Brokered Private Placement PreveCeutical Announces Update to Non-Brokered Private Placement PreveCeutical Announces Update to Private Placement PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects PreveCeutical Announces Non-Brokered Private Placement BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference PreveCeutical Announces Change of Auditors BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board